PROVETOP

Biotinylated Human LILRA3/CD85e Protein

Catalog No: LILRA3-HB001

Species
Human
Expression System
HEK293
Tag
His, Avi

Product overview

Recombinant Biotinylated Human LILRA3/CD85e Protein is expressed in HEK293 cells with a His tag and Avi tag at the C-terminus. It contains amino acid residues Gly24-Glu439 (UniProt accession: Q8N6C8).

Product Details

Molecular Aliases
CD85e; HM31; HM43; ILT6; ILT-6; LILRA3; LIR4; LIR-4HM43e3; LIR4HM43e3
Protein Length
Gly24-Glu439
Expression System
HEK293
Theoretical Molecular Weight
The protein has a predicted MW of 47.9 kDa. Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result.
Purity
> 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC
Endotoxin
Less than 1 EU per μg by the LAL method.
Buffer / Formulation
Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
State
Lyophilized
Storage Conditions
-20 to -80°C for 12 months as supplied from date of receipt. -80°C for 3 months after reconstitution. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Reconstitution Advice
Dissolve the lyophilized protein in distilled water. Please refer to the Certificate of Analysis for detailed instructions.

Data Display

Bis-Tris PAGE
LILRA3-HB001 Bis-Tris-PAGE-white result

Biotinylated Human LILRA3 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

SEC-HPLC
LILRA3-HB001 SEC-HPLC result

The purity of Biotinylated Human LILRA3 is greater than 95% as determined by SEC-HPLC.

Background

Human LILRA3, also known as Leukocyte Ig-like receptor 4 (LIR-4), CD85 antigen-like family member E, Immunogobulin-like transcript 6 (ILT-6) and monocyte inhibitory receptor HM43/HM31, is a 70 kD Ig superfamily member that belongs to the leukocyte receptor complex/cluster. Mature LILRA3 is 416 amino acids (aa) in length and contains four C2-type Ig-like domains. Unlike other LILR family members, LILRA3 is actively secreted. LILRA3 acts as soluble receptor for class I MHC antigens. LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1 or LILRB2. Binds with high affinity to the surface of monocytes, leading to abolish LPS-induced TNF-alpha production by monocytes.

References

  1. Ordó?ez, D, Sánchez, A J, Martínez-Rodríguez, J E, et al. Multiple sclerosis associates with LILRA3 deletion in Spanish patients[J]. Genes & Immunity, 2009, 10(6):579-585.

Have questions about this product?

Our technical team can help with product selection, application questions and order support.

Contact Technical Support